您当前的位置:
首页 >
文章列表页 >
Chinese experts consensus on quality control standards for tumor organoids diagnosis and treatment platform (2026 version)
更新时间:2026-11-05
    • Chinese experts consensus on quality control standards for tumor organoids diagnosis and treatment platform (2026 version)

    • China Oncology   (2026)
    • CLC: R73-3
    • Received:04 November 2026,

    移动端阅览

  • The Society of Cancer Multidisciplinary Diagnosis and Treatment of China Anti-Cancer Association, The Society of Cancer Endocrinology of China Anti-Cancer Association. Chinese experts consensus on quality control standards for tumor organoids diagnosis and treatment platform (2026 version)[J/OL]. China Oncology, 2026. DOI:

  •  
  •  

0

Views

0

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Chinese experts consensus on quality control standards for tumor organoids diagnosis and treatment platform (2022 version)
General guidelines for the construction of tumor organoids expert consensus (2026 edition)
Chinese expert consensus on imaging‑guided evaluation of resectability for ovarian cancer (2025 edition)
Shanghai expert consensus on the diagnosis and treatment of cancer pain (2026 edition)
Key research advances shaping clinical practice in early breast cancer in 2025: progress and perspectives

Related Author

Society of Cancer Endocrinology, China Anti-Cancer Association The
Society of Cancer Multidisciplinary Diagnosis and Treatment, China Anti-Cancer Association The
Clinical Application Branch of Organoid Technology, China Medicinal Biotechnology Association
Working Committee on Organoid Research and Application, Chinese Society for Cell Biology
Committee of Organoids and Organ-on-a-Chip Technology, China Anti-Cancer Association
Clinical Data and Sample Repository Committee of Chinese Research Hospital Association
Biobank Branch of China Medicinal Biotechnology Association
Clinical Precision Medicine Professional Committee of Chinese Medical Doctor Association

Related Institution

Department of Breast Surgery, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University
Department of Radiology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University
Committee of Breast Cancer Society, Chinese Anti-Cancer Association; Clinical Precision Medicine Professional Committee, Chinese Medical Doctor Association; Tumor Heterogeneity and Personalized Therapy Professional Committee, Chinese Anti-Cancer Association
Department of Medical Oncology, The Fifth Medical Center, Chinese PLA General Hospital
Department of Breast Surgery, the First Affiliated Hospital of China Medical University
0